beta blocker: be used for hyperthyroidism

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents agent
Weight: 0.65
, high blood pressure
Weight: 0.63
, heart disease
Weight: 0.63
, vasodilator
Weight: 0.62
Siblings atenolol
Weight: 0.53
, lung cancer
Weight: 0.33
, cystic fibrosis
Weight: 0.33
, agonist
Weight: 0.32
, blood clot
Weight: 0.32

Related properties

Property Similarity
be used for hyperthyroidism 1.00
be used in hyperthyroidism 1.00
cause hyperkalemia 0.78
be used in hypertension 0.78
be contraindicated in diabetes mellitus 0.78
cause hypoglycemia 0.78
be called hypertension 0.77
be contraindicated in pulmonary edema 0.77
be used in esophageal varices 0.77
be contraindicated in patients with asthma 0.77

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.49
Rule weight: 0.66
Evidence weight: 0.95
Similarity weight: 0.77
Evidence: 0.89
Plausible(high blood pressure, be called hypertension) ⋁
Evidence: 0.40
¬ Typical(beta blocker, be used for hyperthyroidism)

Plausibility inheritance from parent to child

0.04
Rule weight: 0.09
Evidence weight: 0.54
Similarity weight: 0.77
Evidence: 0.49
Plausible(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.89
¬ Plausible(high blood pressure, be called hypertension)

Remarkability exclusitivity betweem a parent and a child

0.24
Rule weight: 0.58
Evidence weight: 0.53
Similarity weight: 0.77
Evidence: 0.81
¬ Remarkable(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.57
¬ Remarkable(high blood pressure, be called hypertension)

Remarkability from parent implausibility

0.32
Rule weight: 0.42
Evidence weight: 0.99
Similarity weight: 0.77
Evidence: 0.89
Plausible(high blood pressure, be called hypertension) ⋁
Evidence: 0.81
Remarkable(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.49
¬ Plausible(beta blocker, be used for hyperthyroidism)

Salient implies Plausible

0.19
Rule weight: 0.28
Evidence weight: 0.66
Similarity weight: 1.00
Evidence: 0.49
Plausible(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.66
¬ Salient(beta blocker, be used for hyperthyroidism)

Similarity expansion

0.75
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 1.00
Evidence: 0.40
Typical(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.20
¬ Typical(beta blocker, be used in hyperthyroidism)
0.71
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 1.00
Evidence: 0.81
Remarkable(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.89
¬ Remarkable(beta blocker, be used in hyperthyroidism)
0.69
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 1.00
Evidence: 0.49
Plausible(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.37
¬ Plausible(beta blocker, be used in hyperthyroidism)
0.68
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 1.00
Evidence: 0.66
Salient(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.59
¬ Salient(beta blocker, be used in hyperthyroidism)
0.58
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.78
Evidence: 0.81
Remarkable(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.68
¬ Remarkable(beta blocker, be contraindicated in diabetes mellitus)
0.58
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.77
Evidence: 0.81
Remarkable(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.67
¬ Remarkable(beta blocker, be contraindicated in patients with asthma)
0.57
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.78
Evidence: 0.81
Remarkable(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.72
¬ Remarkable(beta blocker, cause hypoglycemia)
0.57
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.77
Evidence: 0.81
Remarkable(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.73
¬ Remarkable(beta blocker, be used in esophageal varices)
0.57
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.77
Evidence: 0.81
Remarkable(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.75
¬ Remarkable(beta blocker, be contraindicated in pulmonary edema)
0.56
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.78
Evidence: 0.81
Remarkable(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.86
¬ Remarkable(beta blocker, cause hyperkalemia)
0.56
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.78
Evidence: 0.81
Remarkable(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.87
¬ Remarkable(beta blocker, be used in hypertension)
0.55
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.77
Evidence: 0.66
Salient(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.48
¬ Salient(beta blocker, be used in esophageal varices)
0.54
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.78
Evidence: 0.40
Typical(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.33
¬ Typical(beta blocker, cause hyperkalemia)
0.53
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.77
Evidence: 0.49
Plausible(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.39
¬ Plausible(beta blocker, be used in esophageal varices)
0.52
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.77
Evidence: 0.40
Typical(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.34
¬ Typical(beta blocker, be used in esophageal varices)
0.52
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.78
Evidence: 0.40
Typical(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.36
¬ Typical(beta blocker, be used in hypertension)
0.52
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.78
Evidence: 0.66
Salient(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.66
¬ Salient(beta blocker, cause hyperkalemia)
0.51
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.78
Evidence: 0.49
Plausible(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.45
¬ Plausible(beta blocker, cause hyperkalemia)
0.51
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.78
Evidence: 0.66
Salient(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.70
¬ Salient(beta blocker, be used in hypertension)
0.50
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.78
Evidence: 0.49
Plausible(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.49
¬ Plausible(beta blocker, be used in hypertension)
0.49
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.77
Evidence: 0.66
Salient(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.74
¬ Salient(beta blocker, be contraindicated in pulmonary edema)
0.49
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.78
Evidence: 0.66
Salient(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.77
¬ Salient(beta blocker, cause hypoglycemia)
0.47
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.78
Evidence: 0.66
Salient(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.87
¬ Salient(beta blocker, be contraindicated in diabetes mellitus)
0.46
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.77
Evidence: 0.66
Salient(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.87
¬ Salient(beta blocker, be contraindicated in patients with asthma)
0.46
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.77
Evidence: 0.49
Plausible(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.60
¬ Plausible(beta blocker, be contraindicated in pulmonary edema)
0.44
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.78
Evidence: 0.49
Plausible(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.64
¬ Plausible(beta blocker, cause hypoglycemia)
0.43
Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.77
Evidence: 0.40
Typical(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.58
¬ Typical(beta blocker, be contraindicated in pulmonary edema)
0.41
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.78
Evidence: 0.40
Typical(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.64
¬ Typical(beta blocker, cause hypoglycemia)
0.40
Rule weight: 0.85
Evidence weight: 0.60
Similarity weight: 0.78
Evidence: 0.49
Plausible(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.78
¬ Plausible(beta blocker, be contraindicated in diabetes mellitus)
0.39
Rule weight: 0.85
Evidence weight: 0.60
Similarity weight: 0.77
Evidence: 0.49
Plausible(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.78
¬ Plausible(beta blocker, be contraindicated in patients with asthma)
0.34
Rule weight: 0.85
Evidence weight: 0.52
Similarity weight: 0.78
Evidence: 0.40
Typical(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.81
¬ Typical(beta blocker, be contraindicated in diabetes mellitus)
0.34
Rule weight: 0.85
Evidence weight: 0.51
Similarity weight: 0.77
Evidence: 0.40
Typical(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.82
¬ Typical(beta blocker, be contraindicated in patients with asthma)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.89
Similarity weight: 1.00
Evidence: 0.66
Salient(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.40
¬ Typical(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.81
¬ Remarkable(beta blocker, be used for hyperthyroidism)

Typical implies Plausible

0.38
Rule weight: 0.48
Evidence weight: 0.79
Similarity weight: 1.00
Evidence: 0.49
Plausible(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.40
¬ Typical(beta blocker, be used for hyperthyroidism)

Typicality and Rermarkability incompatibility between a parent and a child

0.09
Rule weight: 0.51
Evidence weight: 0.24
Similarity weight: 0.77
Evidence: 0.81
¬ Remarkable(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.94
¬ Typical(high blood pressure, be called hypertension)

Typicality inheritance from parent to child

0.17
Rule weight: 0.48
Evidence weight: 0.44
Similarity weight: 0.77
Evidence: 0.40
Typical(beta blocker, be used for hyperthyroidism) ⋁
Evidence: 0.94
¬ Typical(high blood pressure, be called hypertension)